In conclusion, we contribute new insights into the somatic characterization of LLS CRC, postulating MSH3 and POLD1 double somatic alterations as an underlying cause of MSI phenotype in CRCs with unexplained loss of IHC MSH2/MSH6 expression. This evidence concerns the gene MSH3 and colorectal carcinoma.